₹ 106.91
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Parmax Pharma Limited primarily manufactures active pharmaceutical ingredients (APIs), including ampicillin, amoxicillin, cephalexin, and nalidixic acid. The company also intends to expand its activities into the formulation of finished dosage forms such as tablets, capsules, ointments, and injectables. Established on November 2, 1994, the firm's corporate headquarters are located in Rajkot, India.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Data is available to registered users only